However, subsequent to the confirmation of ACKR3 as a receptor of CXCL12, a plethora of studies have verified that the binding of CXCL12 and ACKR3 can also activate the STAT3 pathway, thereby fostering tumor development. Here, STAT3 is linked to neoplasm.